Brief: Genetic Signatures Says Restructuring Expected To Result In Up To 30 Redundancies
30/03/2026 02:40
March 30 (Reuters) - Genetic Signatures Ltd GSS.AX: GENETIC SIGNATURES ORGANISATIONAL RESTRUCTURE RESTRUCTURING EXPECTED TO RESULT IN UP TO 30 REDUNDANCIES ESTIMATES COST REDUCTION OF A$5 MILLION FROM FY2027 Further company coverage: GSS.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genetic Signatures
See all newsBrief: Genetic Signatures Says Anne Lockwood To Conclude As Interim Managing Director
Brief: Genetic Signatures Logs Q3 Sales A$3 Mln
Australia's Genetic Signatures extends gain on deal with Danish hospital
Australia's Genetic Signatures jumps on supply agreement with Denmark hospital
Brief: Genetic Signatures Signs Danish Supply Agreement